Starling Oncology, Inc. (STLN)
NASDAQ: STLN · Real-Time Price · USD
5.17
+0.04 (0.78%)
At close: Aug 4, 2026, 4:00 PM EDT
5.22
+0.05 (0.97%)
After-hours: Aug 4, 2026, 7:31 PM EDT
Starling Oncology Market Cap
Starling Oncology has a market cap or net worth of $516.91 million as of August 4, 2026. Its market cap has increased by 53.67% in one year.
Market Cap
516.91M
Enterprise Value
598.04M
1-Year Change
53.67%
Ranking
Category
Stock Price
$5.17
ChartMarket Cap Chart
Since July 23, 2021, Starling Oncology's market cap has increased from $990.00 to $516.91M, an increase of 52,213,209.49%. That is a compound annual growth rate of 1,266.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 516.91M | 47.59% |
| Dec 31, 2025 | 350.24M | 1,400.09% |
| Dec 31, 2024 | 23.35M | -84.48% |
| Dec 29, 2023 | 150.45M | 22.52% |
| Dec 30, 2022 | 122.80M | -82.81% |
| Dec 31, 2021 | 714.18M | 72,139,108.08% |
| Jul 23, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| InnovAge Holding | 1.46B |
| The Pennant Group | 1.36B |
| AMN Healthcare Services | 1.30B |
| U.S. Physical Therapy | 1.18B |
| Nutex Health | 1.08B |
| GMR Solutions | 968.29M |
| Charming Medical | 504.26M |
| Strata Critical Medical | 483.68M |